News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Omeros Corporation - Common Stock
(NQ:
OMER
)
9.690
+0.530 (+5.79%)
Streaming Delayed Price
Updated: 3:44 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Omeros Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call
↗
December 01, 2025
Omeros received $240 million upfront, with total deal value reaching up to $2.1 billion.
Via
Stocktwits
Topics
Intellectual Property
Omeros (OMER) Q3 2025 Earnings Call Transcript
↗
November 17, 2025
Omeros (OMER) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Derivatives
Earnings
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
↗
November 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 14, 2025
Via
Benzinga
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Omeros Corp Stock Soars A Whopping 136% Pre-Market After Novo Nordisk Agrees To Buy Its Drug Candidate For Blood Disorder
↗
October 15, 2025
Via
Stocktwits
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
Earnings Preview: Omeros
↗
August 13, 2025
Via
Benzinga
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
↗
November 14, 2025
Via
Benzinga
Examining the Future: Omeros's Earnings Outlook
↗
November 12, 2025
Via
Benzinga
Breakout Momentum Plays You Need to Know About
↗
October 23, 2025
Three stocks may draw the attention of momentum investors—QURE spiked in September, OMER in October, and SDST has almost 1,000% in upside potential.
Via
MarketBeat
4 Biotech Stocks Lifting Off As Momentum Builds
↗
October 21, 2025
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and major indexes reach record levels.
Via
Benzinga
In today's session, these stocks are experiencing unusual volume.
↗
October 17, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings
↗
October 17, 2025
Via
Benzinga
In today's session, these stocks are experiencing unusual volume.
↗
October 16, 2025
Unusual volume stocks are being observed in Thursday's session.
Via
Chartmill
Satellogic, Hewlett Packard Enterprise, Bitfarms And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
October 16, 2025
Via
Benzinga
Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
↗
October 16, 2025
Via
Benzinga
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
↗
October 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
Via
The Motley Fool
Omeros Stock Logs Best Session Ever After HC Wainwright Doubles Target On Novo Nordisk Deal; Retail Sees Big Upside
↗
October 15, 2025
The rally followed H.C. Wainwright’s price target hike to $20 on the back of a $2.1 billion licensing deal with Novo Nordisk for zaltenibart.
Via
Stocktwits
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today
↗
October 15, 2025
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.
Via
Benzinga
Topics
Stocks
Omeros Stock Skyrockets After Novo Nordisk Strikes $2.1B Rare Disease Drug Deal
↗
October 15, 2025
Omeros stock jumps 164% as Novo Nordisk acquires global rights to zaltenibart, with potential milestones reaching $2.1 billion and tiered royalties.
Via
Benzinga
Gold Gains Over 1%; Abbott Shares Fall After Q3 Results
↗
October 15, 2025
Via
Benzinga
Omeros Rockets Skyward on $2.1 Billion Novo Nordisk Deal, Reshaping Biotech Landscape
October 15, 2025
In a dramatic turn of events that sent shockwaves through the biotechnology sector, Omeros Corporation (NASDAQ: OMER) witnessed its stock catapult by an astounding nearly 150% after announcing a...
Via
MarketMinute
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 15, 2025
Via
Benzinga
Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk
↗
October 15, 2025
Novo Nordisk is licensing exclusive global rights to the company's experimental treatment for rare blood and kidney diseases.
Via
Investor's Business Daily
Here are the top movers in Wednesday's session.
↗
October 15, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via
Chartmill
Gapping stocks in Wednesday's session
↗
October 15, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.
Via
Chartmill
S&P 500 Gains 1%; Bank of America Posts Upbeat Earnings
↗
October 15, 2025
Via
Benzinga
Topics
Stocks
Omeros Posts 2,652 Percent Sales Jump
↗
August 14, 2025
Via
The Motley Fool
Omeros Corp (NASDAQ:OMER) Reports Q2 2025: Narrowed Losses, Regulatory Progress, and Market Optimism
↗
August 14, 2025
Omeros Corp (OMER) reports Q2 2025 with narrowed losses, progress on narsoplimab FDA approval, and strategic debt restructuring. Shares rise on regulatory optimism.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
